Epilepsy care guidelines for low- and middle- income countries: From WHO mental health GAP to national programs

BMC Medicine

Volumn 10, Issue , 2012, Pages

  Katchanov, Juri ^a,b   Birbeck, Gretchen L ^c,d  

^a Vivantes Auguste Viktoria Klinikum   (Germany)

^b QUEEN ELIZABETH CENTRAL HOSPITAL   (Malawi)

^c East Lansing   (United States)

^d Chikankata Hospital   (Zambia)

Author keywords

clinical officer; Non physician healthcare worker; treatment gap; variations in care

Indexed keywords

ADAPTATION; EPILEPSY; HEALTH CARE ACCESS; HEALTH CARE ORGANIZATION; HEALTH PROMOTION; HUMAN; INTEGRATED HEALTH CARE SYSTEM; LOWEST INCOME GROUP; MENTAL HEALTH; PATIENT CARE; PERCEPTION; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; SHORT SURVEY; TREATMENT PLANNING;

DEVELOPING COUNTRIES; EPILEPSY; GUIDELINES AS TOPIC; HEALTH POLICY; HUMANS; WORLD HEALTH; WORLD HEALTH ORGANIZATION;

EID: 84866493170     PISSN: None     EISSN: 17417015     Source Type: Journal    
DOI: 10.1186/1741-7015-10-107     Document Type: Short Survey

References (33)

1. Ngugi AK, Bottomley C, Kleinschmidt I, Sander JW, Newton CR. Estimation of the burden of active and life-time epilepsy: a meta-analytic approach. Epilepsia 2010, 51(5):883-890. 10.1111/j.1528-1167.2009.02481.x, 3410521, 20067507.
2. Ngugi AK, Kariuki SM, Bottomley C, Kleinschmidt I, Sander JW, Newton CR. Incidence of epilepsy: a systematic review and meta-analysis. Neurology 2011, 77(10):1005-1012. 10.1212/WNL.0b013e31822cfc90, 3171955, 21893672.
3. Meyer AC, Dua T, Ma J, Saxena S, Birbeck G. Global disparities in the epilepsy treatment gap: a systematic review. Bull World Health Organ 2010, 88(4):260-266. 10.2471/BLT.09.064147, 2855595, 20431789.
4. Gumnit RJ, Walczak TS. Guidelines for essential services, personnel, and facilities in specialized epilepsy centers in the United States. Epilepsia 2001, 42(6):804-814.
5. Labiner DM, Bagic AI, Herman ST, Fountain NB, Walczak TS, Gumnit RJ. Essential services, personnel, and facilities in specialized epilepsy centers--revised 2010 guidelines. Epilepsia 2010, 51(11):2322-2333. 10.1111/j.1528-1167.2010.02648.x, 20561026.
6. Nunes VD, Sawyer L, Neilson J, Sarri G, Cross JH. Diagnosis and management of the epilepsies in adults and children: summary of updated NICE guidance. Bmj 2012, 344:e281. 10.1136/bmj.e281, 22282528.
7. Ehrhardt S, Meyer CG. Transfer of evidence-based medical guidelines to low- and middle-income countries. Trop Med Int Health 2012,
8. WHO mhGAP: Scaling up care for mental, neurological and substance use disorders. 2011, WHO., http://wwwwhoint/mental_health/mhgap_final_englishpdf
9. WHO mhGAP Newsletter. 2011, WHO., http://wwwhoint/mental_health/mhGAP_nl_jun2011_enpdf
10. Birbeck G, Hesdorffer D. The geography of epilepsy: a fatal disease in resource-poor settings. Neurology 2011, 77(2):96-97. 10.1212/WNL.0b013e318223c7c7, 21653887.
11. Mbuba CK, Ngugi AK, Newton CR, Carter JA. The epilepsy treatment gap in developing countries: a systematic review of the magnitude, causes, and intervention strategies. Epilepsia 2008, 49(9):1491-1503. 10.1111/j.1528-1167.2008.01693.x, 18557778.
12. Chinnock P, Siegfried N, Clarke M. Is evidence-based medicine relevant to the developing world?. PLoS Med 2005, 2(5):e107. 10.1371/journal.pmed.0020107, 1140939, 15916456.
13. Schunemann HJ, Fretheim A, Oxman AD. Improving the use of research evidence in guideline development: 13. Applicability, transferability and adaptation. Health Res Policy Syst 2006, 4:25. 10.1186/1478-4505-4-25, 1712227, 17156457.
14. Maitland K, Kiguli S, Opoka RO, Engoru C, Olupot-Olupot P, Akech SO, Nyeko R, Mtove G, Reyburn H, Lang T, et al. Mortality after fluid bolus in African children with severe infection. N Engl J Med 2011, 364(26):2483-2495. 10.1056/NEJMoa1101549, 21615299.
15. De Boer HM. "Out of the shadows": a global campaign against epilepsy. Epilepsia 2002, 43(Suppl 6):7-8.
16. Dua T, Barbui C, Clark N, Fleischmann A, Poznyak V, van Ommeren M, Yasamy MT, Ayuso-Mateos JL, Birbeck GL, Drummond C, et al. Evidence-based guidelines for mental, neurological, and substance use disorders in low- and middle-income countries: summary of WHO recommendations. PLoS Med 2011, 8(11):e1001122. 10.1371/journal.pmed.1001122, 3217030, 22110406.
17. Yemadje LP, Houinato D, Quet F, Druet-Cabanac M, Preux PM. Understanding the differences in prevalence of epilepsy in tropical regions. Epilepsia 2011, 52(8):1376-1381. 10.1111/j.1528-1167.2011.03099.x, 21627649.
18. Preux PM, Druet-Cabanac M. Epidemiology and aetiology of epilepsy in sub-Saharan Africa. Lancet Neurol 2005, 4(1):21-31. 10.1016/S1474-4422(04)00963-9, 15620854.
19. Radhakrishnan K. Challenges in the management of epilepsy in resource-poor countries. Nat Rev Neurol 2009, 5(6):323-330. 10.1038/nrneurol.2009.53, 19455183.
20. Birbeck GL. Epilepsy care in developing countries: part I of II. Epilepsy Curr 2010, 10(4):75-79. 10.1111/j.1535-7511.2010.01362.x, 2912535, 20697498.
21. Anand K, Jain S, Paul E, Srivastava A, Sahariah SA, Kapoor SK. Development of a validated clinical case definition of generalized tonic-clonic seizures for use by community-based health care providers. Epilepsia 2005, 46(5):743-750. 10.1111/j.1528-1167.2005.41104.x, 15857442.
22. de Bittencourt PR, Adamolekum B, Bharucha N, Carpio A, Cossio OH, Danesi MA, Dumas M, Fernandes JG, Genton P, Manreza ML, et al. Epilepsy in the tropics: II. Clinical presentations, pathophysiology, immunologic diagnosis, economics, and therapy. Epilepsia 1996, 37(11):1128-1137. 10.1111/j.1528-1157.1996.tb01036.x, 8917066.
23. Kvalsund MP, Birbeck GL. Epilepsy care challenges in developing countries. Curr Opin Neurol 2012, 25(2):179-186. 10.1097/WCO.0b013e328350baf8, 22322413.
24. Birbeck GL, French JA, Perucca E, Simpson DM, Fraimow H, George JM, Okulicz JF, Clifford DB, Hachad H, Levy RH. Evidence-based guideline: Antiepileptic drug selection for people with HIV/AIDS: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Ad Hoc Task Force of the Commission on Therapeutic Strategies of the International League Against Epilepsy. Neurology 2012, 78(2):139-145. 10.1212/WNL.0b013e31823efcf8, 22218281.
25. Winkler AS, Schaffert M, Schmutzhard E. Epilepsy in resource poor countries--suggestion of an adjusted classification. Epilepsia 2007, 48(5):1029-1030. 10.1111/j.1528-1167.2007.01009_1.x, 17509005.
26. Birbeck GL. Revising and refining the epilepsy classification system: Priorities from a developing world perspective. Epilepsia 2012, 53(Suppl 2):18-21.
27. Fretheim A, Schunemann HJ, Oxman AD. Improving the use of research evidence in guideline development: 15. Disseminating and implementing guidelines. Health Res Policy Syst 2006, 4:27. 10.1186/1478-4505-4-27, 1712226, 17156459.
28. Baskind R, Birbeck G. Epilepsy care in Zambia: a study of traditional healers. Epilepsia 2005, 46(7):1121-1126. 10.1111/j.1528-1167.2005.03505.x, 1224751, 16026565.
29. Oxman AD, Schunemann HJ, Fretheim A. Improving the use of research evidence in guideline development: 16. Evaluation. Health Res Policy Syst 2006, 4:28. 10.1186/1478-4505-4-28, 1702533, 17156460.
30. Fountain NB, Van Ness PC, Swain-Eng R, Tonn S, Bever CT. Quality improvement in neurology: AAN epilepsy quality measures: Report of the Quality Measurement and Reporting Subcommittee of the American Academy of Neurology. Neurology 2011, 76(1):94-99. 10.1212/WNL.0b013e318203e9d1, 21205698.
31. Kvalsund M, Mbewe E, Mulenga J, Atadzhanov M, Haworth A, Chomba E, Birbeck G. Quality indicators for epilepsy care in Zambia: Roadwork for the WHO Mental Health Gap Action (mh GAP) program. American Academy of Neurology Annual Meeting 2012 P07116, April 2012 2012; New Orleans 2012, , http://wwwabstracts2viewcom/aan/viewphp?nu=AAN12L_P07_116&terms
32. Grilli R, Magrini N, Penna A, Mura G, Liberati A. Practice guidelines developed by specialty societies: the need for a critical appraisal. Lancet 2000, 355(9198):103-106. 10.1016/S0140-6736(99)02171-6, 10675167.
33. Shekelle PG, Woolf SH, Eccles M, Grimshaw J. Clinical guidelines: developing guidelines. Bmj 1999, 318(7183):593-596. 10.1136/bmj.318.7183.593, 1115034, 10037645.